Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Loading...
Community
/
United States
/
Healthcare
/
Talkspace
TALK
Talkspace
Regulatory Limits And Competition Will Slow Growth But Unlock Value
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
24 Aug 25
Updated
24 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$3.50
23.7% undervalued
intrinsic discount
24 Aug
US$2.67
1Y
51.7%
7D
3.9%
Loading
1Y
51.7%
7D
3.9%
Author's Valuation
US$3.5
23.7% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$3.5
23.7% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-82m
342m
2018
2020
2022
2024
2025
2026
2028
Revenue US$342.2m
Earnings US$32.1m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
16.88%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$32.09m
Earnings '28
x
21.64x
PE Ratio '28
=
US$694.51m
Market Cap '28
US$694.51m
Market Cap '28
/
163.17m
No. shares '28
=
US$4.26
Share Price '28
US$4.26
Share Price '28
Discounted to 2025 @ 6.78% p.a.
=
US$3.50
Fair Value '25
